Picture of Spexis AG logo

SPEX Spexis AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Spexis: Closing Of Capital Commitment Of $4.5 Mln From SGI To Enable Phase 3 Study

April 18 (Reuters) - Spexis Ag  SPEXN.S :
    * SPEXIS ANNOUNCES CLOSING OF CAPITAL COMMITMENT OF USD 4.5
MILLION FROM SPRIM GLOBAL INVESTMENTS (SGI) TO ENABLE INITIATION
OF COLIFIN® PHASE 3 STUDY
    * SPEXIS ANNOUNCES CLOSING OF CAPITAL COMMITMENT OF USD 4.5
MILLION FROM SPRIM GLOBAL INVESTMENTS (SGI) TO ENABLE INITIATION
OF COLIFIN® PHASE 3 STUDY
    * FUNDING TO ENABLE IMMEDIATE INITIATION OF COPILOT STUDY,
FIRST
OF TWO PHASE 3 COLIFIN® STUDIES; FIRST-PATIENT-IN EXPECTED IN
JUNE 2023
    * COMMITMENT STRUCTURED AS A MIX OF SECURED DEBT AND
SUBORDINATED
DEBT MANDATORILY CONVERTING INTO EQUITY

Source text for Eikon:  ID:nEQ9rjF84a 
Further company coverage:  SPEXN.S 

 (Reporting by Berlin Newsroom)
 ((berlin.newsroom@thomsonreuters.com;))

Recent news on Spexis AG

See all news